Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
dolasetron mesylate
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
Phase:
Phase III, Phase II
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
NCI, Other
Protocol IDs:
CDR0000069401
, U10CA037420, URCC-U1902, URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742
2.
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
Phase:
Phase III
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CDR0000068694
, URCC-U3901, NCI-P01-0180, NCT00020657
3.
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
Phase:
Phase II
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CDR0000066969
, URCC-U3997, NCI-V99-1528, NCT00003817
4.
Antiemetic Retreatment Protocol with Single-Dose Intravenous MDL 73,147EF in Patients Receiving High-Dose (at Least 80 mg/sqm) Cisplatin (Summary Last Modified 01/92)
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
18 to 90
Sponsor:
Protocol IDs:
MSKCC-90151
, NCI-V91-0013
5.
A Dose Escalation Tolerance Study of Intravenous MDL 73,147EF in Patients Receiving Chemotherapy Regimens Containing High-Dose (at least 100 mg/sqm) Cisplatin (Summary Last Modified 01/92)
Phase:
Phase I
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-90150
, NCI-V91-0012
6.
Randomized Comparative Study of 1 vs 2 Doses of Oral Dolasetron Mesylate/Dexamethasone as Antiemesis Prophylaxis in Patients Receiving Cisplatin (Summary Last Modified 10/95)
Phase:
No phase specified
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-95038
, NCI-V95-0708
7.
Randomized, Double-Blind, Comparative Study of the Antiemetic Effectiveness of Single Dose IV Dolasetron Mesylate vs IV Ondansetron in Patients Receiving First-Line CDDP Chemotherapy (Summary Last Modified 06/93)
Phase:
No phase specified
Type:
Supportive care
Status:
Completed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-92141
, NCI-V92-0193
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Follow Us:
Twitter
YouTube
Facebook
RSS
Other Versions:
Mobile
|
Español
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov
NIH…Turning Discovery Into Health
®